franzino

It’s A because the moment you lose the patent protection, a horde of copycats come in and make a generic version of your drug, therefore killing your margins. From an analyst’s point of view when forecasting FCF, knowing how long that built in protection against new entrants lasts is important.
C is somewhat correct(so is B for that matter) but A is more correct, at least how they present it in the curriculum.